日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers.

托法替尼用于预防晚期间皮素表达癌症患者体内针对LMB-100免疫毒素的抗药抗体形成

Skorupan Nebojsa, Peer Cody J, Zhang Xianyu, Choo-Wosoba Hyoyoung, Ahmad Mehwish I, Lee Min-Jung, Rastogi Shraddha, Sato Nahoko, Yu Yunkai, Pegna Guillaume Joe, Steinberg Seth M, Kalsi Shelley S, Cao Liang, Figg William D, Trepel Jane B, Pastan Ira, FitzGerald David, Alewine Christine

An update on the status of HSP90 inhibitors in cancer clinical trials

癌症临床试验中 HSP90 抑制剂的最新进展

Rastogi, Shraddha; Joshi, Abhinav; Sato, Nahoko; Lee, Sunmin; Lee, Min-Jung; Trepel, Jane B; Neckers, Len

Structural and functional complexity of HSP90 in cellular homeostasis and disease

HSP90在细胞稳态和疾病中的结构和功能复杂性

Chiosis, Gabriela; Digwal, Chander S; Trepel, Jane B; Neckers, Len

A Single-Arm, Open-Label Phase II Study of ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma

ONC201治疗复发/难治性转移性乳腺癌和晚期子宫内膜癌的单臂、开放标签II期研究

Atkins, Sarah L P; Greer, Yoshimi Endo; Jenkins, Sarah; Gatti-Mays, Margaret E; Houston, Nicole; Lee, Sunmin; Lee, Min-Jung; Rastogi, Shraddha; Sato, Nahoko; Burks, Christina; Annunziata, Christina M; Lee, Jung-Min; Nagashima, Kunio; Trepel, Jane B; Lipkowitz, Stanley; Zimmer, Alexandra S

Systemic immune changes accompany combination treatment with immunotoxin LMB-100 and nab-paclitaxel

免疫毒素LMB-100与白蛋白紫杉醇联合治疗会伴随全身免疫变化。

Pegna, Guillaume Joe; Lee, Min-Jung; Peer, Cody J; Ahmad, Mehwish I; Venzon, David J; Yu, Yunkai; Yuno, Akira; Steinberg, Seth M; Cao, Liang; Figg, William D; Donahue, Renee N; Hassan, Raffit; Pastan, Ira; Trepel, Jane B; Alewine, Christine

Efficacy and exploratory biomarker analysis of entinostat plus exemestane in advanced or recurrent breast cancer: phase II randomized controlled trial

恩替诺特联合依西美坦治疗晚期或复发性乳腺癌的疗效及探索性生物标志物分析:II期随机对照试验

Iwata, Hiroji; Nakamura, Rikiya; Masuda, Norikazu; Yamashita, Toshinari; Yamamoto, Yutaka; Kobayashi, Kokoro; Tsurutani, Junji; Iwasa, Tsutomu; Yonemori, Kan; Tamura, Kenji; Aruga, Tomoyuki; Tokunaga, Eriko; Kaneko, Koji; Lee, Min-Jung; Yuno, Akira; Kawabata, Azusa; Seike, Toshihiro; Kaneda, Ayumi; Nishimura, Yozo; Trepel, Jane B; Saji, Shigehira

Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

卡博替尼联合纳武利尤单抗治疗对免疫检查点抑制剂疗法耐药的转移性尿路上皮癌患者的I期扩展研究

Girardi, Daniel M; Niglio, Scot A; Mortazavi, Amir; Nadal, Rosa; Lara, Primo; Pal, Sumanta K; Saraiya, Biren; Cordes, Lisa; Ley, Lisa; Ortiz, Olena Sierra; Cadena, Jacqueline; Diaz, Carlos; Bagheri, Hadi; Redd, Bernadette; Steinberg, Seth M; Costello, Rene; Chan, Keith S; Lee, Min-Jung; Lee, Sunmin; Yu, Yunkai; Gurram, Sandeep; Chalfin, Heather J; Valera, Vladimir; Figg, William D; Merino, Maria; Toubaji, Antoun; Streicher, Howard; Wright, John J; Sharon, Elad; Parnes, Howard L; Ning, Yang-Min; Bottaro, Donald P; Cao, Liang; Trepel, Jane B; Apolo, Andrea B

A phase II trial of the super-enhancer inhibitor Minnelide™ in advanced refractory adenosquamous carcinoma of the pancreas

一项针对晚期难治性胰腺腺鳞癌的超级增强剂抑制剂Minnelide™的II期临床试验

Skorupan, Nebojsa; Ahmad, Mehwish I; Steinberg, Seth M; Trepel, Jane B; Cridebring, Derek; Han, Haiyong; Von Hoff, Daniel D; Alewine, Christine

E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group

E2112:激素受体阳性晚期乳腺癌患者接受内分泌治疗联合恩替诺特或安慰剂的随机III期临床试验。ECOG-ACRIN癌症研究组试验

Connolly, Roisin M; Zhao, Fengmin; Miller, Kathy D; Lee, Min-Jung; Piekarz, Richard L; Smith, Karen L; Brown-Glaberman, Ursa A; Winn, Jennifer S; Faller, Bryan A; Onitilo, Adedayo A; Burkard, Mark E; Budd, George T; Levine, Ellis G; Royce, Melanie E; Kaufman, Peter A; Thomas, Alexandra; Trepel, Jane B; Wolff, Antonio C; Sparano, Joseph A

Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma: A Phase 2 Nonrandomized Controlled Trial

卡非佐米、来那度胺和地塞米松序贯来那度胺维持治疗预防高危冒烟型骨髓瘤患者出现症状性多发性骨髓瘤:一项 II 期非随机对照试验

Kazandjian, Dickran; Hill, Elizabeth; Dew, Alexander; Morrison, Candis; Roswarski, Joseph; Korde, Neha; Emanuel, Michael; Petrosyan, Ani; Bhutani, Manisha; Calvo, Katherine R; Dulau-Florea, Alina; Kwok, Mary; Lee, Min-Jung; Lee, Sunmin; Lindenberg, Liza; Mailankody, Sham; Manasanch, Elisabet; Maric, Irina; Mena, Esther; Patel, Nisha; Tageja, Nishant; Trepel, Jane B; Turkbey, Baris; Wang, Hao-Wei; Wang, Weixin; Yuan, Constance; Zhang, Yong; Braylan, Raul; Choyke, Peter; Stetler-Stevenson, Maryalice; Steinberg, Seth M; Figg, William D Sr; Roschewski, Mark; Landgren, Ola